NCT00564226 - SSR240600C Treatment in Women With Overactive Bladder | Biotech Hunter

Enrollment

345

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions

Overactive Bladder

Interventions

DRUG

SSR240600C

oral administration

DRUG

tolterodine

oral administration

DRUG

placebo

oral administration

Trial Locations (7)

Sanofi-Aventis Aministrative Office, Bridgewater

Sanofi-Aventis Administrative Office, Laval

Sanofi-Aventis Administrative Office, Prague

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Porto Salvo